<DOC>
	<DOCNO>NCT01986270</DOCNO>
	<brief_summary>The objective study compare efficacy , toleration safety eletriptan 40mg 80mg , sumatriptan 25mg 50mg , placebo give orally subject acute migraine .</brief_summary>
	<brief_title>Comparative Study Oral Eletriptan ( 40mg 80mg ) , Oral Sumatriptan ( 25mg 50mg ) Placebo</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Sumatriptan</mesh_term>
	<mesh_term>Eletriptan</mesh_term>
	<criteria>Subjects expect suffer least one acute attack migraine , without aura , 6 week ( The diagnosis migraine comply criterion propose International Headache Society ( IHS ) ) Subjects capable take medication outpatient , record effect medication . Pregnant breastfeed woman Migraine subject also suffer concomitant frequent ( nonmigrainous ) headache , define six attack per month average .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>